The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth.

Seda Hanife Oğuz Beyza Seda Boyraz Banu Ertürk Bulent Okan Yildiz

Published in: Endocrine (2023)

PCOS and androgen excess appear to be prevalent among transgender people AFAB. Transgender individuals AFAB with HA or PCOS may exhibit an unfavorable cardiometabolic risk profile compared to those without any PCOS component. Assessment of androgen excess and the specific components of PCOS at baseline could inform long-term management.

Keyphrases

polycystic ovary syndrome
insulin resistance
hiv testing
risk factors
metabolic syndrome
type diabetes
adipose tissue
gestational age
hepatitis c virus
pregnancy outcomes